PCA
BMY icon

Pallas Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Pallas Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6M Sell
92,264
-3,893
-4% -$227K 0.21% 93
2025
Q4 		$5.19M Buy
96,157
+63,750
+197% +$3.07M 0.17% 102
2025
Q3 		$1.46M Buy
32,407
+9,972
+44% +$466K 0.05% 259
2025
Q2 		$1.04M Sell
22,435
-3,802
-14% -$187K 0.04% 322
2025
Q1 		$1.6M Sell
26,237
-1,101
-4% -$64.2K 0.07% 216
2024
Q4 		$1.55M Sell
27,338
-809
-3% -$45.2K 0.07% 171
2024
Q3 		$1.49M Buy
28,147
+9,537
+51% +$447K 0.06% 170
2024
Q2 		$789K Buy
18,610
+9,536
+105% +$427K 0.04% 235
2024
Q1 		$492K Buy
9,074
+2,373
+35% +$121K 0.02% 284
2023
Q4 		$344K Sell
6,701
-207
-3% -$10.9K 0.02% 301
2023
Q3 		$354K Buy
+6,908
New +$423K 0.02% 273

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pallas Capital Advisors's BMY Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4% in Q1 2026, selling an estimated $227K and leaving 92,264 shares worth $5.6M. The position accounts for 0.21% of the portfolio, ranked #93.

Pallas Capital Advisors first reported a position in BMY in Q3 2023 and has held it in 11 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Pallas Capital Advisors held 92,264 shares of Bristol-Myers Squibb worth $5.6M as of Q1 2026.
  • Pallas Capital Advisors sold 3,893 Bristol-Myers Squibb shares in Q1 2026, an estimated $227K.
  • Bristol-Myers Squibb made up 0.21% of Pallas Capital Advisors's portfolio in Q1 2026, its #93 holding.
  • Pallas Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 11 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.